Steroid-converting enzymes in human ovarian carcinomas

Justin C. Chura, Hyung S. Ryu, Marc Simard, Donald Poirier, Yves Tremblay, Doris C. Brooker, Charles H. Blomquist, Peter A Argenta

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent. We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E 2 ) and testosterone (T), and inhibition by isoform-specific inhibitors were used to estimate the contributions of 17β-HSD isoforms. Activity levels were highest for estrone sulfatase, followed, respectively by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD. E 2 /T activity ratios varied widely between samples. A 17β-HSD type 1 inhibition pattern was observed in 23% of the samples and a type 2 pattern in 25%. E 2 formation from estrone sulfate (E 1 S) was detected in 98% (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases. Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.

Original languageEnglish (US)
Pages (from-to)51-58
Number of pages8
JournalMolecular and Cellular Endocrinology
Volume301
Issue number1-2
DOIs
StatePublished - Mar 25 2009

Fingerprint

3-Hydroxysteroid Dehydrogenases
Steroids
Carcinoma
Enzymes
Tumors
Protein Isoforms
Estrogens
Sulfatases
Neoplasms
3(17)-hydroxysteroid dehydrogenase
Testosterone
Estradiol
Neoplasm Metastasis
Messenger RNA
Therapeutics

Keywords

  • 17β-Hydroxysteroid dehydrogenase
  • 3α-Hydroxysteroid dehydrogenase
  • 3β-Hydroxysteroid dehydrogenase
  • Estrone sulfatase
  • Ovarian cancer
  • Steroid metabolism

Cite this

Chura, J. C., Ryu, H. S., Simard, M., Poirier, D., Tremblay, Y., Brooker, D. C., ... Argenta, P. A. (2009). Steroid-converting enzymes in human ovarian carcinomas. Molecular and Cellular Endocrinology, 301(1-2), 51-58. https://doi.org/10.1016/j.mce.2008.07.015

Steroid-converting enzymes in human ovarian carcinomas. / Chura, Justin C.; Ryu, Hyung S.; Simard, Marc; Poirier, Donald; Tremblay, Yves; Brooker, Doris C.; Blomquist, Charles H.; Argenta, Peter A.

In: Molecular and Cellular Endocrinology, Vol. 301, No. 1-2, 25.03.2009, p. 51-58.

Research output: Contribution to journalArticle

Chura, JC, Ryu, HS, Simard, M, Poirier, D, Tremblay, Y, Brooker, DC, Blomquist, CH & Argenta, PA 2009, 'Steroid-converting enzymes in human ovarian carcinomas', Molecular and Cellular Endocrinology, vol. 301, no. 1-2, pp. 51-58. https://doi.org/10.1016/j.mce.2008.07.015
Chura JC, Ryu HS, Simard M, Poirier D, Tremblay Y, Brooker DC et al. Steroid-converting enzymes in human ovarian carcinomas. Molecular and Cellular Endocrinology. 2009 Mar 25;301(1-2):51-58. https://doi.org/10.1016/j.mce.2008.07.015
Chura, Justin C. ; Ryu, Hyung S. ; Simard, Marc ; Poirier, Donald ; Tremblay, Yves ; Brooker, Doris C. ; Blomquist, Charles H. ; Argenta, Peter A. / Steroid-converting enzymes in human ovarian carcinomas. In: Molecular and Cellular Endocrinology. 2009 ; Vol. 301, No. 1-2. pp. 51-58.
@article{9d1578ce15a246ddbbbe0421f1d3a785,
title = "Steroid-converting enzymes in human ovarian carcinomas",
abstract = "Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent. We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E 2 ) and testosterone (T), and inhibition by isoform-specific inhibitors were used to estimate the contributions of 17β-HSD isoforms. Activity levels were highest for estrone sulfatase, followed, respectively by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD. E 2 /T activity ratios varied widely between samples. A 17β-HSD type 1 inhibition pattern was observed in 23{\%} of the samples and a type 2 pattern in 25{\%}. E 2 formation from estrone sulfate (E 1 S) was detected in 98{\%} (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases. Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.",
keywords = "17β-Hydroxysteroid dehydrogenase, 3α-Hydroxysteroid dehydrogenase, 3β-Hydroxysteroid dehydrogenase, Estrone sulfatase, Ovarian cancer, Steroid metabolism",
author = "Chura, {Justin C.} and Ryu, {Hyung S.} and Marc Simard and Donald Poirier and Yves Tremblay and Brooker, {Doris C.} and Blomquist, {Charles H.} and Argenta, {Peter A}",
year = "2009",
month = "3",
day = "25",
doi = "10.1016/j.mce.2008.07.015",
language = "English (US)",
volume = "301",
pages = "51--58",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Steroid-converting enzymes in human ovarian carcinomas

AU - Chura, Justin C.

AU - Ryu, Hyung S.

AU - Simard, Marc

AU - Poirier, Donald

AU - Tremblay, Yves

AU - Brooker, Doris C.

AU - Blomquist, Charles H.

AU - Argenta, Peter A

PY - 2009/3/25

Y1 - 2009/3/25

N2 - Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent. We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E 2 ) and testosterone (T), and inhibition by isoform-specific inhibitors were used to estimate the contributions of 17β-HSD isoforms. Activity levels were highest for estrone sulfatase, followed, respectively by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD. E 2 /T activity ratios varied widely between samples. A 17β-HSD type 1 inhibition pattern was observed in 23% of the samples and a type 2 pattern in 25%. E 2 formation from estrone sulfate (E 1 S) was detected in 98% (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases. Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.

AB - Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent. We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E 2 ) and testosterone (T), and inhibition by isoform-specific inhibitors were used to estimate the contributions of 17β-HSD isoforms. Activity levels were highest for estrone sulfatase, followed, respectively by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD. E 2 /T activity ratios varied widely between samples. A 17β-HSD type 1 inhibition pattern was observed in 23% of the samples and a type 2 pattern in 25%. E 2 formation from estrone sulfate (E 1 S) was detected in 98% (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases. Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.

KW - 17β-Hydroxysteroid dehydrogenase

KW - 3α-Hydroxysteroid dehydrogenase

KW - 3β-Hydroxysteroid dehydrogenase

KW - Estrone sulfatase

KW - Ovarian cancer

KW - Steroid metabolism

UR - http://www.scopus.com/inward/record.url?scp=60249091167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60249091167&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2008.07.015

DO - 10.1016/j.mce.2008.07.015

M3 - Article

C2 - 18723074

AN - SCOPUS:60249091167

VL - 301

SP - 51

EP - 58

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -